These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24594485)

  • 1. An international conference on "Pharmaceutical products in the environment: is there a problem?" in the framework of the EU PHARMAS Project.
    Roig B; Thomas O
    Chemosphere; 2014 Nov; 115():1-3. PubMed ID: 24594485
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals and personal care products: research needs for the next decade.
    Brooks BW; Huggett DB; Boxall AB
    Environ Toxicol Chem; 2009 Dec; 28(12):2469-72. PubMed ID: 19908931
    [No Abstract]   [Full Text] [Related]  

  • 3. In response: governmental perspective.
    Maack G
    Environ Toxicol Chem; 2014 Sep; 33(9):1918-20. PubMed ID: 25138029
    [No Abstract]   [Full Text] [Related]  

  • 4. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research.
    Caldwell DJ; Mastrocco F; Margiotta-Casaluci L; Brooks BW
    Chemosphere; 2014 Nov; 115():4-12. PubMed ID: 24636702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings of an international conference on ‘‘Pharmaceutical products in the environment: Is there a problem?’’ in the framework of the EU PHARMAS Project, June 3-4, 2013, Nimes, France.
    Chemosphere; 2014 Nov; 115():1-99. PubMed ID: 25489650
    [No Abstract]   [Full Text] [Related]  

  • 6. Genes help predict drugs' environmental impacts.
    Lubick N
    Environ Sci Technol; 2008 Aug; 42(15):5382-3. PubMed ID: 18754449
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeating history: pharmaceuticals in the environment.
    Ankley GT; Brooks BW; Huggett DB; Sumpter JP
    Environ Sci Technol; 2007 Dec; 41(24):8211-7. PubMed ID: 18200843
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenge: do pharmaceuticals present a risk to the environment, and what needs to be done to answer the question?
    Sumpter JP
    Environ Toxicol Chem; 2014 Sep; 33(9):1915. PubMed ID: 25138028
    [No Abstract]   [Full Text] [Related]  

  • 9. A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluent.
    Caldwell DJ; Mertens B; Kappler K; Senac T; Journel R; Wilson P; Meyerhoff RD; Parke NJ; Mastrocco F; Mattson B; Murray-Smith R; Dolan DG; Straub JO; Wiedemann M; Hartmann A; Finan DS
    Environ Toxicol Chem; 2016 Apr; 35(4):813-22. PubMed ID: 26183919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving environmental risk assessment of human pharmaceuticals.
    Ågerstrand M; Berg C; Björlenius B; Breitholtz M; Brunström B; Fick J; Gunnarsson L; Larsson DG; Sumpter JP; Tysklind M; Rudén C
    Environ Sci Technol; 2015 May; 49(9):5336-45. PubMed ID: 25844810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals in the environment, a prescription for disaster?
    Agamuthu P; Fauziah SH
    Waste Manag Res; 2011 Apr; 29(4):349-50. PubMed ID: 21444587
    [No Abstract]   [Full Text] [Related]  

  • 12. The EU-project ERAPharm. Incentives for the further development of guidance documents?
    Knacker T; Duis K; Ternes T; Fenner K; Escher B; Schmitt H; Römbke J; Garric J; Hutchinson T; Boxall AB
    Environ Sci Pollut Res Int; 2005; 12(2):62-5. PubMed ID: 15859111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
    Laenge R; Steger-Hartmann T; Schweinfurth H
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chlorination on the persistence of pharmaceuticals in the environment.
    Glassmeyer ST; Shoemaker JA
    Bull Environ Contam Toxicol; 2005 Jan; 74(1):24-31. PubMed ID: 15768494
    [No Abstract]   [Full Text] [Related]  

  • 15. International scientists' priorities for research on pharmaceutical and personal care products in the environment.
    Rudd MA; Ankley GT; Boxall AB; Brooks BW
    Integr Environ Assess Manag; 2014 Oct; 10(4):576-87. PubMed ID: 24954797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In response: industry perspective.
    Brown AR
    Environ Toxicol Chem; 2014 Sep; 33(9):1915-8. PubMed ID: 25138027
    [No Abstract]   [Full Text] [Related]  

  • 17. Human pharmaceutical products in the environment - the "problem" in perspective.
    Taylor D; Senac T
    Chemosphere; 2014 Nov; 115():95-9. PubMed ID: 24525259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of pharmaceutical and personal care products on ecological and human health].
    Liu Y; Zhu L; Li J
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):237-40. PubMed ID: 19408672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to the special issue on environmental risk assessment of pharmaceuticals.
    Knacker T; Metcalfe C
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():511-3. PubMed ID: 20821716
    [No Abstract]   [Full Text] [Related]  

  • 20. An international conference on "Pharmaceuticals in the Environment" in a frame of EU Knappe project.
    Roig B; Greenwood R; Barcelo D
    Environ Int; 2009 Jul; 35(5):763-5. PubMed ID: 19246093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.